Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.50 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL359805 | 0.98 | PPARG (0.53) | PPARGLMNANFE2L2PTGS2PTGS1 | |
| SCHEMBL1205879 | 0.98 | PPARG (0.53) | PPARGLMNANFE2L2PTGS2PTGS1 | |
| SCHEMBL5766149 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PTGS2PTGS1 | |
| SCHEMBL5766143 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PTGS2PTGS1 | |
| SCHEMBL29175487 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PTGS2PTGS1 | |
| SCHEMBL11539912 | 0.85 | PTGES2 (0.50) | PPARGLMNANFE2L2PTGS2PTGS1 | |
| SCHEMBL1194569 | 0.78 | PPARG (0.57) | PPARGLMNANFE2L2PTGES2PKM | |
| SCHEMBL19155588 | 0.78 | PPARG (0.57) | PPARGLMNANFE2L2PTGES2PKM | |
| SCHEMBL587895 | 0.78 | PPARG (0.57) | PPARGLMNANFE2L2PTGES2PKM | |
| SCHEMBL3730162 | 0.78 | PPARG (0.57) | PPARGLMNANFE2L2PTGES2PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116284631-B | Three-dimensional covalent organic framework lithium salt containing cage-shaped silsesquioxane, and preparation method and application thereof | 国科广化韶关新材料研究院 | 2024-09-17 | — | — | CN | claimed |
| CN-116344929-A | Lithium metal three-dimensional covalent organic framework quasi-solid electrolyte and preparation method and application thereof | 国科广化韶关新材料研究院 | 2023-06-27 | — | — | CN | claimed |
| CN-116284631-A | Three-dimensional covalent organic framework lithium salt containing cage-shaped silsesquioxane, and preparation method and application thereof | 国科广化韶关新材料研究院 | 2023-06-23 | — | — | CN | claimed |
| CN-116284631-B | Three-dimensional covalent organic framework lithium salt containing cage-shaped silsesquioxane, and preparation method and application thereof | 国科广化韶关新材料研究院 | 2024-09-17 | — | — | CN | disclosed |
| CN-116344929-A | Lithium metal three-dimensional covalent organic framework quasi-solid electrolyte and preparation method and application thereof | 国科广化韶关新材料研究院 | 2023-06-27 | — | — | CN | disclosed |
| CN-116284631-A | Three-dimensional covalent organic framework lithium salt containing cage-shaped silsesquioxane, and preparation method and application thereof | 国科广化韶关新材料研究院 | 2023-06-23 | — | — | CN | disclosed |
| CN-116284631-A | Three-dimensional covalent organic framework lithium salt containing cage-shaped silsesquioxane, and preparation method and application thereof | 国科广化韶关新材料研究院 | 2023-06-23 | — | — | CN | disclosed |